We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

151 hedge funds and large institutions have $521M invested in Sciclone Pharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 49 increasing their positions, 49 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 26

21% more capital invested

Capital invested by funds: $431M → $521M (+$89.3M)

6% more funds holding

Funds holding: 142 → 151 (+9)

0% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 49

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
151
Holders Change
+9
Holders Change %
+6.34%
% of All Funds
4.03%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
37
Increased
49
Reduced
49
Closed
26
Calls
$1.28M
Puts
–
Net Calls
+$1.28M
Net Calls Change
+$1.6M

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$33.4M
2
Invesco
Invesco
Georgia
+$8.03M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$6.24M
4
Principal Financial Group
Principal Financial Group
Iowa
+$4.6M
5
LSV Asset Management
LSV Asset Management
Illinois
+$4.42M

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$12.7M
2
Millennium Management
Millennium Management
New York
-$8.13M
3
NI
Numeric Investors
Massachusetts
-$6.08M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.34M
5
BIT
BlackRock Institutional Trust
California
-$3.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fisher Asset Management
26
Fisher Asset Management
Washington
$3.99M -$2.12M -161,593 -35%
GT
27
Glenmede Trust
Pennsylvania
$3.98M -$1.4M -107,093 -26%
Goldman Sachs
28
Goldman Sachs
New York
$3.88M -$1.35M -103,132 -26%
CCMH
29
Cornerstone Capital Management Holdings
New York
$3.54M +$465K +35,500 +15%
Skandinaviska Enskilda Banken (SEB)
30
Skandinaviska Enskilda Banken (SEB)
Sweden
$3.48M -$1.88M -143,400 -35%
OAM
31
Oxford Asset Management
United Kingdom
$3.47M -$625K -47,666 -15%
Ameriprise
32
Ameriprise
Minnesota
$3.13M +$3.14M +239,635 New
BIM
33
BlackRock Investment Management
Delaware
$2.86M +$555K +42,382 +24%
BIM
34
Bogle Investment Management
Massachusetts
$2.77M +$2.78M +212,150 New
GCP
35
GSA Capital Partners
United Kingdom
$2.73M -$1.35M -103,002 -33%
TCIM
36
TIAA CREF Investment Management
New York
$2.58M +$478K +36,451 +23%
Prudential Financial
37
Prudential Financial
New Jersey
$2.42M +$1.46M +111,300 +150%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$2.31M -$132K -10,100 -5%
AllianceBernstein
39
AllianceBernstein
Tennessee
$2.09M +$282K +21,540 +16%
CAM
40
ClariVest Asset Management
California
$2.08M +$218K +16,600 +12%
PAM
41
Panagora Asset Management
Massachusetts
$1.97M -$166K -12,638 -8%
MCM
42
Matarin Capital Management
New York
$1.94M -$314K -23,977 -14%
MC
43
Menta Capital
California
$1.93M +$726K +55,416 +60%
SFM
44
Systematic Financial Management
New Jersey
$1.83M -$56.5K -4,315 -3%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$1.77M -$38K -2,900 -2%
PPA
46
Parametric Portfolio Associates
Washington
$1.62M -$1.16M -88,806 -42%
State Board of Administration of Florida Retirement System
47
State Board of Administration of Florida Retirement System
Florida
$1.59M -$421K -32,095 -21%
CS
48
Credit Suisse
Switzerland
$1.53M -$2.44M -186,522 -61%
AA
49
ALPS Advisors
Colorado
$1.49M +$149K +11,379 +11%
Macquarie Group
50
Macquarie Group
Australia
$1.45M +$387K +29,500 +36%
1
2
3 4 5

SCLN Hedge Fund Activity: Q2 2016 in Review

151 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q2 2016, worth a combined $521M — up 21% from $431M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new SCLN positions and 26 closed out — a net gain of 11 holders — while 49 added to existing stakes and 49 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $33.4M. The largest seller was Stonepine Capital Management, cutting an estimated $12.7M.

  • 151 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q2 2016, up from 142 in Q1 2016.
  • Funds reported $521M of Sciclone Pharmaceuticals Inc stock for Q2 2016, up 21% quarter-over-quarter.
  • 37 funds opened new Sciclone Pharmaceuticals Inc positions in Q2 2016 and 26 closed out, a net change of +11 holders.
  • The largest Sciclone Pharmaceuticals Inc buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $33.4M added.
  • The largest Sciclone Pharmaceuticals Inc seller in Q2 2016 was Stonepine Capital Management, an estimated $12.7M sold.

Based on aggregated 13F filings for Q2 2016.